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A growing body of evidence indicates that microglia actively remove synapses in vivo,
thereby playing a key role in synaptic refinement and modulation of brain connectivity.
This phenomenon was mainly investigated in immunofluorescence staining and confocal
microscopy. However, a quantification of synaptic material in microglia using these
techniques is extremely time-consuming and labor-intensive. To address this issue,
we aimed to quantify synaptic proteins in microglia using flow cytometry. With this
approach, we first showed that microglia from the healthy adult mouse brain contain
a detectable level of VGLUT1 protein. Next, we found more than two-fold increased
VGLUT1 immunoreactivity in microglia from the developing brain (P15) as compared
to adult microglia. These data indicate that microglia-mediated synaptic pruning mostly
occurs during the brain developmental period. We then quantified the VGLUT1 staining
in microglia in two transgenic models characterized by pathological microglia-mediated
synaptic pruning. In the 5xFAD mouse model of Alzheimer’s disease (AD) microglia
exhibited a significant increase in VGLUT1 immunoreactivity before the onset of amyloid
pathology. Moreover, conditional deletion of TDP-43 in microglia, which causes a
hyper-phagocytic phenotype associated with synaptic loss, also resulted in increased
VGLUT1 immunoreactivity within microglia. This work provides a quantitative assessment
of synaptic proteins in microglia, under homeostasis, and in mouse models of disease.
Keywords: microglia, synaptic pruning, VGLUT1, 5xFAD model, TDP-43 conditional knock-out
INTRODUCTION
Microglia originate through primitive hematopoiesis in the yolk sac and colonize the brain
rudiment during embryonic development (Ginhoux et al., 2010; Schulz et al., 2012; Kierdorf
et al., 2013). During the perinatal period, microglia acquire a highly ramified morphology and
appear evenly distributed throughout the brain parenchyma (Ginhoux and Prinz, 2015). Microglia
in vivo are extremely motile cells exhibiting continuous extension and retraction of their finely
ramified processes, thus performing a ceaseless immunological surveillance of the surrounding
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environment (Davalos et al., 2005; Nimmerjahn et al., 2005;
Hanisch and Kettenmann, 2007). Moreover, microglia
support the formation and consolidation of neural circuits
in the developing brain (Parkhurst et al., 2013; Ueno et al.,
2013; Squarzoni et al., 2014; Zhan et al., 2014; Miyamoto
et al., 2016). Under homeostasis, microglia constantly
interact with synaptic inputs (Wake et al., 2009; Tremblay
et al., 2010), thus mediating a fine-tuning of the synaptic
activity (Kettenmann et al., 2013). Importantly, during
brain development microglia enact displacement/removal
of synaptic inputs, thus actively contributing to synaptic pruning
(Stevens et al., 2007; Paolicelli et al., 2011; Schafer et al., 2012;
Filipello et al., 2018; Lehrman et al., 2018). Very recently,
abnormal synaptic refinement by microglia was also reported
in various mouse models of neurological disorders (Hong
et al., 2016; Lui et al., 2016; Schafer et al., 2016; Vasek et al.,
2016; Paolicelli et al., 2017; Shi et al., 2017; Di Liberto et al.,
2018). A full elucidation of this mechanism will provide a
deeper understanding of the dynamics of brain development,
as well as of neurodevelopmental and neurodegenerative
disorders (Neniskyte and Gross, 2017; Salter and Stevens,
2017). At present, further progress in this field of research
is hampered by the lack of standardized techniques allowing
an accurate estimation of synaptic material in microglia. To
our knowledge, all the available data are essentially generated
with microscopy-based approaches, such as confocal imaging
and electron microscopy (EM; Schafer et al., 2012; Bisht
et al., 2016; Sipe et al., 2016). Modern microscopy provides a
qualitative appraisal of synaptic proteins inside of microglia,
yet for a fast and unbiased quantification, microscopy-based
techniques have some drawbacks. In particular, the spatial
resolution of confocal microscopy may be insufficient to
resolve microglial and synaptic structures when they are less
than few hundreds of nanometers apart from each other
(Weinhard et al., 2018). Given these technical limitations, the
development of alternative approaches is currently in high
demand (Sierra et al., 2013). In the present work, we used flow
cytometry intracellular staining to quantify VGLUT1, which
is a marker for glutamatergic synapses, in microglia acutely
isolated from different mouse models. In flow cytometry,
VGLUT1 immunoreactivity was detected in microglia, but
not in other extra-parenchymal CD45hi brain macrophages.
We then provided evidence that VGLUT1 is localized inside
microglial cells and is not due merely to adhesion of synaptic
proteins on the cell surface. Interestingly, significantly increased
VGLUT1 immunoreactivity was found in microglia from
juvenile mice (post-natal day 15) than in microglia from adult
mice (12-week-old), supporting the hypothesis that synaptic
pruning occurs primarily in brain development. Similarly,
microglia from 2-month-old 5xFAD mice exhibited higher
VGLUT1 staining compared to wild-type controls, indicating
increased pruning of glutamatergic synapses at the early stages
of amyloid pathology. Last, augmented VGLUT1 was also
found in TDP43-deficient microglia, which was previously
shown to exhibit an hyper-phagocytic phenotype (Paolicelli
et al., 2017). By providing a quantitative assessment, our
data consolidate previous evidence concerning the uptake of




All animal experiments were performed with the permission
of the local authorities of the Regional Council of Freiburg
(Regierungspräsidium) and the animal welfare committee of
the University of Freiburg, and with approval of the animal
care and use committees of the Swiss Cantonal Veterinary
Office. All mice used here (including wild-type, Cx3cr1GFP/+,
Vglut1−/−, 5xTgFAD and Cx3cr1CreERT2/+;Tardbpflox/flox)
were bred on a C57BL/6J background and maintained under
specific pathogen-free conditions, in a temperature- and
humidity-controlled facility with a 12 h light-dark cycle. Food
and water were available ad libitum. To minimize gender-
dependent heterogeneity of amyloid pathology in 5xTgFAD
mice, males only were used. 5xTgFAD and wild-type control
mice were analyzed at the age of 2 months, therefore prior to
the amyloid-plaques formation. For all the other experiments
both genders were used, and mice were analyzed at the age of
either 2 months or post-natal day 15 (P15). The generation and
characterization of the Vglut1 knock-out line used here were
previously described (Wojcik et al., 2004). Vglut1 knock-out
mice and control wild-type littermates were analyzed at the
age of P15–P17 because of the premature death owing to
Vglut1-deficiency. To induce the recombination of the Tardbp
floxed allele in microglia, Cx3cr1CreERT2/+;Tardbpflox/flox mice
(TDP-43 conditional knockout) underwent 5 i.p. injections
24 h apart of corn oil-dissolved Tamoxifen (1.5 mg/mouse/day;
Sigma–Aldrich, Buchs, Switzerland). Tamoxifen treatment
began at P30 and mice were sacrificed at P90. Importantly,
the insertion of the Cre transgene downstream of the Cx3cr1
promoter disrupts expression of the endogenous Cx3cr1 gene.
Given the risk of experimental bias due to the monoallelic
expression of Cx3cr1, we used Cx3cr1CreERT2/+;Tardbp+/+
littermates as the wild-type control. The same tamoxifen
treatment was applied on both Cx3cr1CreERT2/+;Tardbpflox/flox
and Cx3cr1CreERT2/+;Tardbp+/+ mice to normalize possible
drug-related effects.
Immunofluorescence
Mice were deeply anesthetized through intraperitoneal (i.p.)
injection of ketamine hydrochloride (Ketavet, Pfizer; dosage
300 mg/kg body weight) and xylazine (Rompun, Bayer
HealthCare; dosage 30 mg/kg body weight). Mice were then
intracardially perfused with ice-cold PBS. Dissected brains were
fixed in 4% PFA (paraformaldehyde) overnight at 4◦C and
subsequently cryoprotected in 30% sucrose solution for 48 h at
4◦C. Frozen whole brains were cut into 60 µm thick coronal
sections. Free-floating sections were pre-incubated for 2 h at
room temperature with blocking solution (PBS + 5% horse serum
and 0.5% Triton X-100) and subsequently incubated 48 h at 4◦C
with the primary antibody solution (PBS + 1% horse serum and
0.5% Triton X-100). Sections were then washed and incubated
overnight at 4◦C with secondary (fluorochrome-conjugated)
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Antibody Product Clone Host Dilution
Anti-Iba1 Wako Chemicals, 019-19741 Polyclonal Rabbit 1:500
Anti-CD68 Bio-Rad, MCA1957GA FA-11 Rat 1:200
Anti-VGLUT1 Merck Millipore, MAB5502 3C10.2 Mouse 1:500
Anti-NeuN Alexa-488 Merck Millipore, MAB377 A60 Mouse 1:1,000
Anti-Amyloid-Beta Biolegend, Sig-39320 6E10 Mouse 1:1,000
Anti-Mouse Alexa-488 Life Technologies, A21202 Polyclonal Donkey 1:1,000
Anti-Rat Alexa-488 Abcam, ab150153 Polyclonal Donkey 1:1,000
Anti-Mouse Alexa-555 Thermo Fisher Scientific, A-21424 Polyclonal Goat 1:1,000
Anti-Mouse Alexa-568 Life Technologies, A11004 Polyclonal Goat 1:1,000
Anti-Rabbit Alexa-647 Life Technologies, A31573 Polyclonal Donkey 1:1,000
Antibody Product Clone Host Dilution
Anti-CD11b BV421 Biolegend, 101235 M1/70 Rat 1:200
Anti-CD45 APC eBioscience, 17-0451-82 30-F11 Rat 1:200
Anti-VGLUT1 PE Merck Millipore, FCMAB335PE 3C10.2 Mouse 0.5 µg/test
Anti-VGLUT1 Oyser550 Synaptic Systems, 135303C3 Polyclonal Rabbit 0.5 µg/test
Anti-Synaptophysin Merck Millipore, MAB5258-20UG SY38 Mouse 0.5 µg/test
IgG1 K Isotype Control PE eBioscience, 12-4714-42 P3.6.2.8.1 Mouse 0.5 µg/test
Anti-HA Tag Oyser550 Synaptic Systems, 245003C3 Polyclonal Rabbit 0.5 µg/test
antibody and DAPI for nuclear staining (1:4,000, Sigma).
After washing sections were mounted with ProLong Diamond
Antifade Mounting Medium (Thermo Fisher Scientific).
Amyloid-β immunostaining was performed on 25 µm thick
coronal sections. Free-floating sections were incubated overnight
with the anti-Aβ 6E10 primary antibody (1:1,000, Biolegend).
Staining with the secondary (fluorochrome-conjugated)
antibody was performed for 2 h at room temperature. Dense-core
plaques were stained with Thiazine-red (2 µM, Sigma) for 5 min
at room temperature. Sections were then counterstained
with DAPI (1:10,000, Sigma) and mounted with fluorescence
mounting medium (DAKO).
Confocal Imaging
Immunostained 60 µm thick brain cryosections were analyzed
by confocal laser scanning ZEISS LSM 510 META microscope.
z-stack images were obtained with either 25×/0.8 NA or
63×/1.4 NA oil-immersion objectives (Zeiss). Microscope
settings: 1.6 µs pixel dwell, resolution 2,048 × 2,048 pixels,
averaging number 4, z-step 0.5 µm, unidirectional acquisition
mode, color depth 12 bit. Confocal images were initially
deconvolved with Huygens Professional software1 using
default parameter settings and subsequently analyzed using
IMARIS software version 7.5.32. Amyloid-β covered area
was calculated with ImageJ using the default auto-threshold.
Manual threshold adjustments were applied if necessary.
Quantification of the VGLUT1+ synaptic inputs was carried out
using the Imaris spot-detection tool. The automatic detection
algorithm was set to identify all VGLUT1+ spots with a
diameter ≥1 µm. For thresholding, 10% of dimmest spots
were excluded.
STED Microscopy
STED images were acquired utilizing STEDYCON technology
(Abberior Instruments GmbH) installed on a ZEISS LSM
1https://svi.nl
2https://www.bitplane.com
510 META confocal microscope carrying a 100×1.45 NA
oil-immersion objectives (Zeiss). Immunofluorescent labeling
for Iba1 and VGLUT1 was carried out as described above.
Anti-mouse-Star580 and anti-rabbit-StarRED (diluted 1:100)
were used as secondary (fluorochrome-conjugated) antibodies.
Secondary antibodies were a kind gift from Dr. Janina Hanne
of Abberior Instruments GmbH3. Raw images were deconvolved
with Huygens Professional software and analyzed in IMARIS
7.5.3 software.
Flow Cytometry
After intracardiac perfusion with ice-cold PBS, brains were
harvested and slowly homogenized with a tissue potter and
filtered through a 70 µm strainer. Myelin was then removed
by centrifugation on 30% percoll gradient. Brain pellets
were sequentially stained with live/dead staining and for the
microglial surface markers CD11b and CD45. Subsequently,
stained samples were fixed and permeabilized using the BD
Cytofix/Cytoperm kit. Eventually, we performed intracellular
staining for the desired synaptic marker. Samples were acquired
on BD FACS Canto II (BD Bioscience) flow cytometer. Raw data
were analyzed with FlowJo v10 (BD Bioscience). See the protocol
for a more detailed description of the method.
Statistics
Graphs and statistics were produced using the Graph-Pad
Prism 5 software package. Statistical difference between two
groups was determined by either a two-tailed unpaired Student’s
t-test or two-tailed Mann–Whitney U-test. To test for normal
distribution, the Kolmogorov–Smirnov test was used. When
the data passed the normality test (α = 0.05), the p-value was
determined with the unpaired Student’s t-test. When the data
did not pass the normality test (α = 0.05), or the N size was too
small, the p-value was determined with the Mann–Whitney U-
test. The exact p-values were reported. Data are shown as the
mean value± SEM.
3https://www.abberior-instruments.com
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RESULTS
VGLUT1 Inclusions Can Be Found in
Adult Hippocampal Microglia
Under Homeostasis
In the adult mouse brain, microglia constantly engage contacts
with the surrounding neuronal dendrites (Supplementary
Figure S1A) and this phenomenon is apparently driven by
neuronal activity (Wake et al., 2009; Tremblay et al., 2010;
Stowell et al., 2019). We analyzed the brain of 12-week-old
mice by confocal imaging, looking for evidence of synaptic
engulfment in microglia. Immunostaining for Iba1 (a marker
for microglia) and VGLUT1 (a marker for glutamatergic
pre-synaptic inputs) showed that microglial processes often
overlap with glutamatergic synapses in both cortex and
dentate gyrus (Figure 1A). To exclude possible bias due
to a non-specific staining, we tested the used anti-VGLUT1
antibody on Vglut1 knock-out (Vglut1−/−) mice (Figure 1B,
Supplementary Figure S1B). Confocal imaging in the cortex
and dentate gyrus shows that the used antibody did not
produce detectable staining in Vglut1−/− mice (Figure 1C).
Moreover, VGLUT1 staining in Thy1-EGFP mice showed that
VGLUT1 synapses are localized in proximity to the neuronal
dendrites (Supplementary Figure S1C). These data together
indicate that the used anti-VGLUT1 antibody was specific for
glutamatergic synapses. We, therefore, decided to focus on
VGLUT1 as a synaptic marker of interest.
In the hippocampus of 12-week-old mice, we could
occasionally observe the presence of VGLUT1 immunoreactivity
localized within the microglial cytoplasm (Figure 1D).
Intracellular localization of VGLUT1 staining was confirmed
by 3D cell reconstruction (Figures 1E,F). Such inclusions were
found in both microglial processes (Supplementary Figure S1D)
and cell bodies (Supplementary Figure S1E). The presence of
VGLUT1 staining inside microglia was further confirmed by
STED microscopy (Figures 1G,H) and 3D cell reconstruction
(Figure 1I). To determine whether VGLUT1 inclusions
in microglia stemmed from phagocytosis of synapses we
performed triple staining for Iba1, VGLUT1, and CD68 (a
marker for phagolysosomes in macrophages). Our images
show that VGLUT1 inclusions in microglia colocalized with
phagosomes (Figures 1J,K). Moreover, 3D reconstruction of the
CD68-positive surface confirmed that the VGLUT1 inclusions
were located within the phagosomes (Figure 1L), indicating
that glutamatergic pre-synaptic inputs were taken up
by phagocytosis.
Although immunofluorescence staining may help appreciate
the presence of glutamatergic synaptic proteins in microglia,
we concluded that confocal imaging does not grant enough
resolution power to reliably discriminate between the synapses
that are truly engulfed and those that are simply juxtaposed
to the microglial processes. Indeed, a recent work suggested
caution to use confocal imaging to investigate synaptic pruning
(Weinhard et al., 2018). As an alternative and complementary
approach, we used flow cytometry to assess and quantify
VGLUT1 immunoreactivity in microglia.
Flow Cytometry Allows for Relative
Quantification of VGLUT1
Immunoreactivity in Microglia From
the Adult Healthy Brain
We first tested whether VGLUT1 staining could be reliably
quantified in adult microglia by flow cytometry. To do so,
we performed intracellular staining for VGLUT1 on brain
homogenates from 12-week-old Cx3cr1GFP/+ mice (gating
strategy in Supplementary Figure S2). We then gated separately
microglia (CD11b+CD45lo population) and brain’s non-myeloid
cells (CD11b−CD45− population; Figure 2A). Microglia
exhibited a weak yet detectable immunoreactivity for VGLUT1.
By contrast, the brain’s non-myeloid cells were strongly positive
for VGLUT1 (Figure 2B). Importantly, no VGLUT1 signal
could be detected in the spleen homogenate, indicating that
the used antibody did not cross-react with antigens outside
the CNS (Supplementary Figure S3A). We then quantified
VGLUT1 immunoreactivity in microglia by comparing
VGLUT1-stained vs. isotype control samples (Figure 2C).
Doing so, we could detect an average of 12.4% (±1.3%)
VGLUT1-positive microglial cells in our samples (Figure 2D).
However, this method of quantification is obviously biased by the
manual gating. To provide an unbiased relative quantification
of the VGLUT1 immunoreactivity (hereafter VGLUT1 IR)
among different cell types, we normalized VGLUT1 Mean-
Fluorescence-Intensity (MFI) to the isotype MFI in each
population of interest (MFI VGLUT1: MFI Isotype, hereafter
‘‘n-MFI’’). Using this formula, VGLUT1 nMFI was determined
in both microglia and CD11b+CD45hi macrophages (CD45hi
MPs) separately (Figure 2E). The CD45hi MPs population
comprises extra-parenchymal myeloid cells (mostly perivascular,
meningeal, and choroid plexus macrophages) which are not
in direct contact with the brain’s parenchyma (Kierdorf
et al., 2019; Brioschi et al., 2020) and therefore should not be
positive for VGLUT1. Indeed, microglia exhibited a VGLUT1
n-MFI = 4.3 ± 0.5 (meaning 4.3-fold increased MFI compared
to the isotype), while no signal was detected in CD45hi MPs
(n-MFI = 1.2 ± 0.1; Figures 2F,F1). Similar results were
obtained staining for the pre-synaptic marker Synaptophysin
(SYN; n-MFI in microglia = 2.6 ± 0.5; n-MFI in CD45hi
MPs = 1.1 ± 0.1; Figures 2G,G1). Overall, these data indicate
that different synaptic markers can be detected and quantified in
microglia, but not in CD45hi MPs, which served as an internal
control (Figure 2H). To rule out possible bias due to unspecific
staining, we performed an additional VGLUT1 staining using
a different antibody clone, which yielded similar n-MFI values
(n-MFI in microglia = 5.4 ± 0.7; Figure 2I). Additionally,
we compared VGLUT1 IR between hippocampal and cortical
microglia from 12-week-old mice. We found that microglia
from hippocampus exhibit a slight, yet significant, increase of
VGLUT1 n-MFI (5.5 ± 0.5) compared to microglia from cortex
(3.9± 0.2; Supplementary Figure S3B). These data indicate that
VGLUT1 IR in microglia varies depending on the brain region.
In summary, this flow cytometry-based approach allowed for
relative quantification of synaptic proteins in microglia from the
adult healthy brain.
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FIGURE 1 | VGLUT1 inclusions can be found in adult hippocampal microglia under homeostasis. (A) In immunohistochemistry, frequent overlaps between Iba1 and
VGLUT1 signals can be detected in the brain cortex and dentate gyrus (DG). (B) Anti-VGLUT1 staining in cortex and dentate gyrus (DG) from both Vglut1+/+
(wild-type) and Vglut1−/− (knock-out) littermates. (C) Quantification of the VGLUT1-positive voxels per stack in cortex (CTX) and dentate gyrus (DG) of both Vglut1+/+
and Vglut1−/− mice (N = 3 mice per group, two sections per mouse; data from a single experiment). (D) Microglial cell at the CA1 hippocampus exhibiting a
VGLUT1 inclusion overlapping with a process (yellow arrowhead). (E) 3D cell reconstruction of the same microglial cell displayed in panel (D). (F) Application of a
clipping surface on the 3D reconstruction discloses the presence of a VGLUT1 inclusion within the microglial process (yellow arrowhead). (G) STED image of a
microglial cell in the CA1 exhibiting a VGLUT1 inclusion (white arrowhead). (H) Orthogonal projection of the imaged in panel (J) showing the intracellular localization
of the VGLUT1 staining. (I) 3D reconstruction of the cell in panel (J) showing the intracellular localization of the VGLUT1 staining. (J) A confocal image of a microglial
cell body exhibiting VGLUT1 inclusion overlapping with a CD68+ phagosome (scale bar 5 µm). (K) Orthogonal projection of the inset area. Note the colocalization
between VGLUT1 and CD68 staining (white spot in the centre of the crosshair). (L) 3D reconstruction of both CD68 (green) and VGLUT1 (blue) signals showing that
the VGLUT1 inclusion is perfectly encased within the microglial phagosomes (white arrowhead).
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FIGURE 2 | Flow cytometry allows for a relative quantification of VGLUT1 immunoreactivity in microglia from both the adult and the developing mouse brain. (A)
FACS plot displaying the gates for both microglia (CD11b+CD45lo population) and brain’s non-myeloid cells (CD11b−CD45− population). (B) FACS plot showing
VGLUT1 immunoreactivity in both microglia and brain’s non-myeloid cells. (C) Microglia from VGLUT1-stained samples exhibit a positive staining, as compared to
isotype control. (D) Percentage of the VGLUT1-positive microglia, fluorescence of the isotype control is used as baseline (N = 6 mice, pooled data from two
independent experiments). (E) FACS plot displaying both microglia (CD11b+CD45lo population) and CD45hi MPs (CD11b+CD45hi population). (F) Fluorescence peak
of the VGLUT1 staining in CD45hi MPs. (F1) Fluorescence peak of the VGLUT1 staining in microglia (anti-VGLUT1-PE, Merck Millipore FCMAB335PE, clone 3C10.2).
(G) Fluorescence peak of the Synaptophysin staining in CD45hi MPs. (G1) Fluorescence peak of the Synaptophysin staining in microglia. (H)
n-MEAN-FLUORESCENCE-INTENSITY (MFI) for VGLUT1 and Synaptophysin in both microglia and CD45hi MPs (VGLUT1 N = 6 mice per group, pooled data from
two independent experiments; Mann–Whitney U-test; ∗∗p = 0.002. Synaptophysin N = 4 mice per group, data from a single experiment; Mann–Whitney
U-test unpaired; ∗p = 0.029). (I) Fluorescence peak of the VGLUT1 staining in microglia using an alternative antibody clone conjugated with a different dye
(Continued)
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FIGURE 2 | Continued
(anti-VGLUT1-Oyster550, Synaptic Systems 135303C3, polyclonal). (J) FACS
plot displaying microglia from either adult (12-week-old) or P15 mice. (K)
Comparison of the VGLUT1 immunoreactivity between adult and
P15 microglia. (L) VGLUT1 staining was not detectable in splenic
macrophages (Sp-MPs). (M) VGLUT1 n-MFI in microglia from P15 and adult
brain, Sp-MPs served as a negative control (adult N = 5 mice per group, P15
N = 7 mice per group, Sp-MPs N = 5 mice per group, data from a single
experiment; unpaired t-test; ∗∗∗p < 0.0001).
VGLUT1 Immunoreactivity in Microglia
Is Intracellular
To prove that the observed VGLUT1 IR in microglia was
derived from a specific intracellular staining, we performed
a control experiment treating brain homogenates with either
FACS buffer or permeabilization buffer. In principle, without
permeabilization, the antibody does not cross the cell membrane,
resulting in a lack of intracellular staining. For this experiment,
we prepared brain homogenates from Cx3cr1GFP/+ mice,
which were split equally into two separate tubes. Half of the
sample was stained for VGLUT1 in FACS buffer, while the
other half was stained using a permeabilization buffer. In flow
cytometry, we gated both microglia (CX3CR1+CD11b+CD45lo)
and non-microglial cells (CX3CR1−CD11b−CD45−) separately
(Supplementary Figure S3C). In samples incubated with
FACS buffer microglia did not exhibit detectable VGLUT1 IR,
which was instead present using the permeabilization buffer
(Supplementary Figure S3D). This difference was even
more remarkable in the non-myeloid cells (Supplementary
Figure S3E). Focusing on microglia, we measured a VGLUT1
n-MFI = 0.9± 0.1 using FACS buffer, and n-MFI = 6.8± 0.9 with
the permeabilization buffer (Supplementary Figure S3F).
This experiment showed that membrane permeabilization
increased VGLUT1 IR in microglia of ∼7-fold (Supplementary
Figure S3G). To summarize, the permeabilization of the cell
membrane was necessary for successful detection of VGLUT1 in
microglia, hence, we concluded that the stained synaptic protein
was located within intracellular compartments.
P15 Microglia Exhibit Increased
VGLUT1 Immunoreactivity as Compared
to Adult Microglia
Early post-natal development is a critical period for brain
maturation and synapse remodeling (Tau and Peterson, 2010).
Recent literature has provided evidence that, in the early
post-natal brain, microglia contribute to maturation of neural
circuits by refining synaptic connections (Paolicelli et al.,
2011; Schafer et al., 2012; Filipello et al., 2018). We hence
aimed to quantify VGLUT1 staining in microglia from the
developing brain (at postnatal day 15, P15) using flow cytometry
(Figure 2J). We found that VGLUT1 IR was increased in
microglia from P15 as compared to adult mice (Figure 2K).
As expected, no VGLUT1 IR was detected in either splenic
macrophages (Sp-MPs; Figure 2L) or CD45hi MPs (not shown).
According to our quantification, we measured 2.2-fold increased
VGLUT1 n-MFI in P15 microglia (8.0 ± 0.5) compared to
adult microglia (3.6 ± 0.2; Figure 2M). These data indicate
that VGLUT1-positive microglia can be found in both the
adult and the juvenile mouse brain. However, microglia during
the post-natal brain development display a significantly higher
VGLUT1 immunoreactivity, suggestive of an increased uptake of
glutamatergic synapses in this period.
Microglia Exhibit Increased
VGLUT1 Immunoreactivity at Early Stages
of Amyloid Pathology
As main pathological hallmarks, Alzheimer’s disease (AD) is
characterized by extracellular deposition of amyloid-β and
intracellular accumulation of phospho-Tau. Alongside, AD
brains feature a progressive loss of neurons and synapses
(Ziegler-Waldkirch and Meyer-Luehmann, 2018). Interestingly,
an increase of microglia-mediated synaptic pruning was recently
indicated as an early pathophysiological event in a mouse model
of AD before full-blown amyloid pathology (Hong et al., 2016).
We then hypothesized that microglia may exhibit increased
content of VGLUT1 protein at early stages of amyloid-β (Aβ)
deposition. To test this hypothesis, we compared VGLUT1 IR in
microglia from amouse model of AD and wild-type controls. For
this experiment, we decided to rely on the 5xTgFAD (hereafter
FAD+) mouse line crossed with the Cx3cr1GFP/+ line to help
visualize microglia during amyloid pathology. In mice carrying
the FAD mutations, amyloid plaques typically start to develop in
the subiculum at 2 months and in the hippocampus 4 months
after birth. Nonetheless, intraneuronal Aβ42 and synaptic
degeneration can be observed at earlier time points (Oakley
et al., 2006). Importantly, amyloid pathology does not involve
the cerebellum. First, we assessed the presence of the amyloid
plaques in the cortex of 2 months old and 7 months old FAD+
mice using both the 6E10 antibody (staining for human APP)
and the thiazine-red staining (staining for fibrillar Aβ). Confocal
imaging showed that, at 2 months of age, no obvious amyloid
deposits can be observed. By contrast, several amyloid plaques
surrounded by plaque-associated microglia are clearly visible at
7 months (Figure 3A). This data indicates that FAD+mice at age
of 2 months do not exhibit signs of obvious amyloid pathology.
We then analyzed VGLUT1 IR in microglia from the cortex of
2months old FAD+ and FAD− (wild-type)mice, whilemicroglia
from the cerebellum were used as a negative control (Figure 3B).
Our flow cytometry analysis revealed a slight, but significant,
increase of the VGLUT1 n-MFI in cortical microglia from FAD+
compared to FAD− mice (6.8 ± 0.4 and 5.1 ± 0.2, respectively;
Figure 3C). By contrast, cerebellar microglia did not show
any significant difference between FAD+ and FAD− mice
(5.8 ± 0.4 and 5.1 ± 0.3, respectively; Figure 3D). In
immunohistochemistry, we assessed the overall density of
VGLUT1 synapses in both cortex (Supplementary Figure S4A)
and cerebellum (Supplementary Figure S4B) of 2 months old
FAD+ and FAD− mice. Our quantification revealed a mild loss
of VGLUT1 synapses in the cortex of FAD+ mice as compared
to wild-type controls (Supplementary Figure S4C). Although
the observed difference did not reach the statistical significance
(p = 0.2), we can cautiously suggest that there is a tendency
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towards a loss of glutamatergic synapses at the age of 2 months.
As expected, no difference in density of VGLUT1 synapses
was found in the cerebellum (Supplementary Figure S4).
To further corroborate these data, we assessed the number
of VGLUT1-positive events in the cortical non-myeloid cells
(CX3CR1−CD11b−CD45− population) using flow cytometry
(Supplementary Figure S4E). Consistently with the previous
observation, a significant reduction (−19% ± 0.04) of the
VGLUT1-positive events was found in the cortex of 2 months old
FAD+ mice in comparison to wild-type mice (Supplementary
Figure S4F). In summary, FAD+ mice display a (mild) loss
of cortical glutamatergic synapses before the formation of
amyloid plaques. At the very same time, cortical microglia
exhibit increased immunoreactivity for VGLUT1, suggesting





Recent work described augmented phagocytosis in microglia
lacking the Tardbp gene, encoding for the RNA-DNA binding-
protein TDP-43. The depletion of TDP-43 in microglia caused
increased phagocytosis of amyloid-β, but also promoted loss
of VGLUT1 synapses, probably because of augmented synaptic
pruning (Paolicelli et al., 2017). As an additional benchmark
for our quantification method, we decided to compare
VGLUT1 IR between TDP-43-deficient and wild-type microglia.
Mice selectively lacking TDP-43 in microglia were generated by
crossing Cx3cr1CreERT2 mice with Tardbpflox/flox mice (Parkhurst
et al., 2013; Paolicelli et al., 2017; Figure 3E). In principle,
this conditional Tamoxifen-inducible mouse model allows to
specifically delete loxP-flanked genes in parenchymal microglia
and other long-lived CNS-associated macrophages (Goldmann
et al., 2013, 2016; Wieghofer et al., 2015). To further explore
the presence of VGLUT1 protein in highly phagocytic microglia,
we assessed the VGLUT1 IR in both Cx3cr1CreERT2;Tardbp+/+
and Cx3cr1CreERT2;Tardbpflox/flox littermates (hereafter wild-type
and TDP-43 cKO, respectively). Starting at P30, all mice
underwent daily injections of Tamoxifen on five consecutive days
to induce Cre-mediated recombination. Successful ablation of
TDP-43 in microglia from Tardbpflox/flox carriers was previously
demonstrated (Paolicelli et al., 2017). After 8 weeks, mice
were euthanized, and brains were analyzed by flow cytometry
(experimental plan in Figure 3F). Unlike wild-type mice, in
the TDP-43 cKO group, we could observe the presence of
two distinct sub-populations of microglia differing in CD11b
intensity (Figure 3G). To explain this phenomenon, we
hypothesize that some microglial cells failed to recombine both
Tardbp alleles, thus generating two populations with different
CD11b expression level. Whether or not this difference in
CD11b expression is caused by an incomplete recombination
of the Tardbpflox/flox locus remains to be established. Besides
this unexpected finding, TDP-43 cKO microglia exhibited
a remarkable increase of VGLUT1 IR (Figure 3H). Our
quantification showed a significant increase of VGLUT1
n-MFI in TDP-43 cKO microglia as compared to wild-type
(4.2 ± 0.1 and 3.1 ± 0.2, respectively; Figure 3I). Again,
VGLUT1 IR was not detectable in CD45hi MPs (not shown).
These data support previous evidence that TDP-43 ablation
in microglia leads to increased engulfment of glutamatergic
synapses (Paolicelli et al., 2017).
DISCUSSION
The first evidence of microglia displacing synapses from
neuronal cell bodies was presented approximately 50 years ago
(Blinzinger and Kreutzberg, 1968). Over the last decade, the
scientific community has witnessed a growing interest in this
topic (Tremblay et al., 2010; Paolicelli et al., 2011; Schafer
et al., 2012). In the mouse brain, the first 2 weeks of postnatal
development are accompanied by a peak in synaptic turnover,
with intense de novo synapse formation and synapse elimination.
Microglia critically contribute to the removal of exuberant and
unnecessary synapses generated across this period, playing an
important role in synaptic pruning. To date, the molecular cues
implicated in this process are largely unknown and it is possible
that different brain cells, other than microglia, secrete factors
modulating this process (Bialas and Stevens, 2013; Vainchtein
et al., 2018). It has been so far shown that a microglia-
mediated synaptic pruning occurs during brain development,
while evidence of synaptic pruning in the healthy adult brain is
still lacking.
We first sought evidence of colocalization between the
pre-synaptic marker VGLUT1 and microglial cytoplasm in the
hippocampus of adult mice by confocal imaging. Our confocal
and STED images disclosed the presence of the pre-synaptic
protein VGLUT1 within microglial processes and cell bodies.
Moreover, such VGLUT1 inclusions were often colocalized with
the phagosomes, indicating that synaptic pruning may still occur
in the hippocampus during adulthood. To provide a quantitative
appraisal of the VGLUT1 protein in microglia we assessed
VGLUT1 immunoreactivity in the CD11b+CD45lo population by
flow cytometry. Our data show that microglia in the adult brain
contain a detectable amount of VGLUT1 protein, which can
be successfully stained and quantified via fluorescence intensity.
Using this approach, we could also show that microglia from the
developing brain contain more than two times the amount of
VGLUT1 found in adult microglia.
Next, we aimed to quantify VGLUT1 in microglia from two
pathological models. First, we assessed the VGLUT1 staining
in microglia from the 5xFAD mouse model of AD. We
found that cortical microglia exhibit a significant increase
of immunoreactivity for VGLUT1 in 2 months old 5xFAD
mice as compared to wild-types. This suggests that microglia
may account, at least partially, for the synaptic degeneration
observed in the early stages of the pathology (Hong et al., 2016;
Shi et al., 2017). Microglia may remove injured/dysfunctional
glutamatergic synapses at early stages of amyloid pathology
via synaptic pruning. Alternatively, we may hypothesize
that Aβ-related toxicity causes a loss of glutamatergic
synapses, debris of which is rapidly scavenged by neighboring
microglia. These two scenarios are not mutually exclusive, and
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FIGURE 3 | Microglia exhibit increased VGLUT1 immunoreactivity at early stages of amyloid pathology and after conditional TDP-43 deletion. (A) Confocal imaging
in the cortex of 2-month-old and 7-month-old 5xFAD × Cx3cr1GFP/+ mice stained with either thiazine-red or the 6E10 antibody. Representative of three mice per
group. (B) FACS plot of microglia extracted from either cortex or cerebellum. A comparison of the VGLUT1 IR between FAD+ and FAD− mice is displayed. (C)
VGLUT1 n-MFI in cortical microglia from either FAD− or FAD+ mice (N = 6 mice per group; pooled data from two independent experiments; unpaired t-test;
∗∗p = 0.005). (D) VGLUT1 n-MFI in cerebellar microglia from either FAD− or FAD+ mice (N = 6 mice per group; pooled data from two independent experiments;
unpaired t-test; non-significant difference). (E) Scheme of the conditional Tardbp knock-out in microglia. (F) Scheme of the experimental design. (G) FACS plot
displaying microglia from wild-type and TDP-43 cKO mice. Note that TDP-43 cKO microglia appeared as two distinct populations. (H) VGLUT1 IR in microglia from
wild-type and TDP-43 cKO mice. (I) VGLUT1 nMFI in TDP-43 cKO microglia compared to wild-type microglia (wild-type N = 4 mice, TDP-43 cKO N = 6 mice, data
from a single experiment; Mann–Whitney U-test; ∗∗p = 0.009).
further studies are needed to determine whether microglia
are directly involved in the synaptic loss observed under
AD-like pathology.
Last, we assessed the presence of VGLUT1 protein in
microglia from the Cx3cr1CreERT2;Tardbpflox/flox mouse line. As
recently described, conditional TDP-43 deletion in microglia
(TDP-43 cKO) induces a highly phagocytic phenotype,
which develops alongside the loss of VGLUT1 synapses
from the cortical parenchyma (Paolicelli et al., 2017). In
flow cytometry, we could detect a significant increase in
VGLUT1 immunoreactivity in TDP-43 cKO microglia,
suggesting augmented pruning of glutamatergic synapses. This
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evidence further corroborates (and integrates) the previously
published data, indicating that the synaptic loss observed in
this transgenic mouse is likely contributed by exaggerated
synaptic pruning.
The quantification of synaptic proteins in microglia by
flow cytometry certainly provides some advantages compared
to the traditional microscopy techniques, such as a much
faster acquisition and analysis of the experimental data.
Nevertheless, there are some important caveats to keep in mind:
(1) Application of this technique is limited by the availability of
antibodies specific for synapses and, at the same time, suitable
for flow cytometry staining. (2) Flow cytometry requires tissue
homogenization with loss of the structural and anatomical
information of the brain’s parenchyma, that is otherwise
preserved in histology. (3) Using flow cytometry, we are unable to
provide a direct visualization of the VGLUT1 immunoreactivity
in microglia, which would help determine the exact localization
of the VGLUT1 inclusions. (4) The presented data do not provide
experimental proof that microglia actively prune synapses from
the neuronal dendrites as opposed to ‘‘simply’’ scavenging
synaptic debris within the brain parenchyma. (5) This method
is not specific for synaptic proteins; indeed, we could also detect
immunoreactivity for GFAP, MAP2, and NeuN in microglia
(not shown), possibly owing to the uptake of dead cells in
the brain.
It is important to note that, in this study,
VGLUT1 immunoreactivity was never found in CD45hi
(extra-parenchymal) macrophages or splenic macrophages,
indicating that the staining did not produce non-specific labeling
of myeloid antigens. Moreover, we provided evidence that the
observed VGLUT1 immunoreactivity was intracellular and not
merely due to adhesion of VGLUT1 proteins to the cell surface.
In conclusion, with this study, we aimed to perform relative
quantification of the synaptic protein VGLUT1 in microglia
during brain development, adulthood, and neurodegeneration
using flow cytometry. This work corroborates previous
evidence, mostly based on imaging techniques, providing a
methodological framework for quantitative assessment which
may help investigate microglia-mediated synapse elimination.
A better understanding of the pathological synaptic pruning
will help design novel therapies for neurodevelopmental and
neurodegenerative disorders.
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FIGURE S1 | (A) Confocal image in the hippocampus of a Thy.1-eGFP mouse
with anti-Iba1 staining showing the interactions between microglial processes and
neuronal dendrites (white arrowheads). A GFP+ inclusion within the microglial
cytoplasm is also visible (yellow arrowhead). (B) Immunohistochemistry in the
mouse cortex for Iba1 (green) and VGLUT1 (red). Diffuse VGLUT1 staining is
present in wild-type (Vglut1+/+), but not in the knock-out (Vglut1−/−) brain. (C)
VGLUT1 synapses (red) were found in proximity to Thy1-GFP neurons (green). 3D
reconstruction highlights the close contact between VGLUT1 synapses and the
neuronal dendrites. (D) A microglial cell in the CA1 exhibiting a VGLUT1 inclusion
within a process (white box and yellow arrowhead). (E) A microglial cell in the
CA1 exhibiting VGLUT1 inclusions in the cell body (white box and yellow
arrowhead).
FIGURE S2 | Gating strategy for microglia, brain CD45hi MPs and splenic MPs.
Cells were hierarchically gated as follows: CD11b+ brain’s myeloid cells→ single
cells→ viable cells→ GFP+ or GFP− (depending on the presence of the
Cx3cr1GFP/+ transgene)→ CD11b+CD45lo population (microglia) and
CD11b+CD45hi population (CD45hi MPs). Representative gating strategy for (A)
wild-type brain, (B) Cx3cr1GFP/+ brain, and (C) spleen.
FIGURE S3 | (A) VGLUT1 immunoreactivity is present in the brain tissue, but not
in the spleen. (B) VGLUT1 n-MFI in microglia from either cortex or hippocampus
(N = 6 mice per group; pooled data from two independent experiments; unpaired
t-test; *p = 0.0149). (C) FACS plot showing all brain cells from Cx3cr1GFP/+ mice,
gated as CD11b+ and CD11b− populations. (D) Microglia were gated as
CD11b+CX3CR1+CD45lo population. (E) Non-myeloid cells were gated as
CD11b−CX3CR1−CD45− population. VGLUT1 IR in either gate was detectable
only in presence of permeabilization buffer. (F) VGLUT1 n-MFI in microglia stained
with either FACS buffer or permeabilization buffer (N = 4 samples per group; data
from a single experiment; Mann–Whitney U-test; ∗p < 0.028). (G) VGLUT1 MFI
fold-change between non-permeabilized and permeabilized microglia (four
samples per group).
FIGURE S4 | (A) Iba1 (red) and VGLUT1 (green) staining in the cortex of FAD−
and FAD+ mice at the age of 2 months. (B) Iba1 (red) and VGLUT1 (green)
staining in the cerebellum of FAD− and FAD+ mice at the age of 2 months. (C)
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Quantification of VGLUT1+ puncta per field (100 µm2) in the cortex of FAD− and
FAD+ mice at 2 months (N = 3 mice per group, average of two sections per
mouse; data from a single experiment; Mann–Whitney U-test; non-significant
difference). (D) Quantification of VGLUT1+ puncta per field (100 µm2) in the
cerebellum of FAD− and FAD+ mice at 2 months (N = 3 mice per group, average
of two sections per mouse; data from a single experiment; Mann–Whitney U-test;
non-significant difference). (E) VGLUT1 immunoreactivity in the non-myeloid cells
(CD11b−CD45−) from the cortex of either FAD− and FAD+ mice at 2 months. (F)
Percentage of the VGLUT1-positive events in the brain’s non-myeloid cells (gated
as in panel E) were measured. The plot displays the fold change in the FAD+
group (N = 4 mice per group; data from a single experiment; Mann–Whitney
U-test; ∗p < 0.029).
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